Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

This study has been completed.
Information provided by (Responsible Party):
Revalesio Corporation Identifier:
First received: December 20, 2010
Last updated: September 30, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)